Patients with rheumatoid arthritis or psoriasis who took tumor necrosis factor inhibitors were 38% less likely to develop type 2 diabetes over 12 years, while those who took methotrexate and hydroxychloroquine were 23% and 46% less likely, respectively, to develop the disease compared with those who took other disease-modifying antirheumatic drugs, according to a study in the Journal of the American Medical Association. The researcher noted that the study was observational and did not demonstrate causality.

Full Story:
HealthDay News

Related Summaries